Results 31 to 40 of about 1,721 (143)

Impact of combined oral contraceptives and progestin‐only pills on psychological and sexual well‐being of women with endometriosis: A systematic review

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Hormonal treatments for endometriosis (combined oral contraceptives/progestin‐only pills) do not show increased psychological or sexual risks compared with placebo. When pain is effectively controlled, these therapies appear well tolerated and may improve overall well‐being.
Noemi Salmeri, Martina Piccini, Francesca Caprara, Edgardo Somigliana, Paola Viganò, Paolo Vercellini   +5 more
wiley   +1 more source

Post Hoc Analysis of a Previous Study of Estetrol 15 mg/Drospirenone 3 mg Combination for Dysmenorrhea and Uterine Bleeding in Adenomyosis Patients

Reproductive Medicine and Biology, Volume 25, Issue 1, January/December 2026.
ABSTRACT Purpose To clarify the efficacy and safety of the estetrol 15 mg/drospirenone 3 mg combination among Japanese women with adenomyosis by post hoc analyses of a previous randomized clinical study. Methods Post hoc analyses were performed using data from a 16‐week, multi‐center, randomized, double‐blinded, placebo‐controlled, parallel‐group study,
Tasuku Harada, Takao Kobayashi, Eri Koga, Masayoshi Nogami, Ayaka Sasahara, Toshiaki Takayanagi, Masashi Hirayama, Yutaka Osuga   +7 more
wiley   +1 more source

New ways in therapy of abnormal uterine bleedings related to adenomyosis [PDF]

Гинекология, 2015
The purpose of research was a comparison of the effect of a three-phase combined oral contraceptive (COC) containing estradiol valerate and dienogest in dynamic mode and single agent containing dienogest, to reduce menstrual blood loss on the background ...
N N Rukhliada, E I Biriukova, M A Melnikova, D M Gasimova   +3 more
doaj  

Combined Management of a Rare Case of an Incarcerated Intrauterine Device: Case Report and Review of the Literature

Case Reports in Obstetrics and Gynecology, Volume 2026, Issue 1, 2026.
Background Hormonal intrauterine systems are widely used for long‐acting reversible contraception and for managing gynecological conditions such as heavy menstrual bleeding and endometrial hyperplasia. Although rare, complications such as uterine embedment and perforation can occur, potentially leading to device malfunction or injury displacement. This
Stefano Restaino, Federico Paparcura, Elisa Rizzante, Silvia Zermano, Annalisa Graziano, Antonio Ferraro, Margherita Cuman, Alice Poli, Martina Arcieri, Lorenza Driul, Giuseppe Vizzielli, Gabriel Levin   +11 more
wiley   +1 more source

Dienogest [PDF]

Reactions Weekly, 2021
  +4 more sources

Drug therapy efficacy for the syndrome of chronic pelvic pain relapses in perinatal endometriosis

Кубанский научный медицинский вестник, 2015
Comparative analysis of drug therapy efficacy for the syndrome of chronic pelvic pain relapses in perinatal endometriosis has been presented: it included dienogest monotherapy and combined interleukin-2 (il-2) and dienogest therapy.
R. A. Musolyants, I. I. Kutsenko, E. I. Kravtsova, N. R. Danilova   +3 more
doaj  

Nociceptive Nerve‐Derived CGRP Exacerbates Uterine Fibrogenesis in Adenomyosis by Promoting CD140b+ CD146+ Fibroblast Differentiation

Advanced Science, Volume 12, Issue 45, December 4, 2025.
This study investigates adenomyosis fibrosis in relation to nociceptive nerves. Nociceptive nerve‐secreted CGRP promotes RAMP1hi CD140b+ CD146+ fibroblast differentiation into myofibroblasts through ERK activation, causing severe fibrosis. Rimegepant‐induced CGRP/RAMP1 signaling blockade alleviates fibrosis and restores fertility in a mouse model. This
Zi Ye, Anning Zhao, Xia Li, Yanqing Hao, Dong Huang, Jianmin Chen, Tiantian Li, Yangyang Dai, Wenchao Sun, Lie Ma, Songying Zhang, Liaobing Xin   +11 more
wiley   +1 more source

Effectiveness of dienogest in improving quality of life in Asian women with endometriosis (ENVISIOeN): interim results from a prospective cohort study under real-life clinical practice

BMC Women's Health, 2019
Background Dienogest has been shown to substantially improve endometriosis-associated symptoms such as debilitating chronic pelvic pain, and in turn, health-related quality of life (HRQoL).
Kitirat Techatraisak, Andon Hestiantoro, Soon Ruey, Maria Jesusa Banal-Silao, Mee-Ran Kim, Seok Ju Seong, Syarief Thaufik, Christiane Ahlers, So Young Shin, Byung Seok Lee   +9 more
doaj   +1 more source

Ovarian reserve may influence the outcome of bone mineral density in patients with long-term use of dienogest

SAGE Open Medicine, 2021
Objective: Long-term administration of dienogest, which is known to have effect on bone mineral density, is frequently done in patients with endometriosis and adenomyosis, but a few studies focused on the bone mineral density changes after finishing the ...
N Yamamoto, O Wada-Hiraike, M Hirano, T Hirata, M Harada, Y Hirota, K Koga, T Fujii, Y Osuga   +8 more
doaj   +1 more source

Hormone Profiles After Planned Low Energy Availability Exposure in Naturally Menstruating and Hormonal Contraceptive Using Physique Athletes

European Journal of Sport Science, Volume 25, Issue 12, December 2025.
ABSTRACT This observational study investigated the potential influence of hormonal contraceptive (HC) use on selected hormonal biomarkers (estradiol, total testosterone, IGF‐1, cortisol, triiodothyronine, and leptin) that respond to diet and physical training–induced low energy availability (LEA).
Ritva Mikkonen, Anthony C. Hackney, Juha Hulmi, Ville Isola, Juha Ahtiainen, Johanna Ihalainen   +5 more
wiley   +1 more source